Weeva Lotion contains Permethrin. Weeva Lotion uses:
Weeva Lotion is indicated for the treatment of scabies.
|Brand Name:||Weeva Lotion|
|Therapeutic Class:||Parasiticidal preparations|
|Manufacturer:||GREEN CROSS REMEDIES|
|Last Updated:||2020-11-20 18:15:00|
Weeva Lotion contains Permethrin 5.0 %. Weeva Lotion doses
For 15 gm Tube:
For 30 gm Tube:
In scabies patients, skin discomfort, usually described as burning, stinging or tingling occurs in a few individuals soon after the cream is applied. Other transient signs and symptoms of irritation including erythema, edema, eczema, rash and pruritus which may follow the treatment of scabies with Weeva Lotion are generally considered to be the part of the natural history of scabies. In patients treated for scabies, itching may persist for up to 4 weeks post-treatment. This is generally regarded as due to an allergic reaction to the dead mites under the skin and is not necessarily indicative of a treatment failure.
Weeva Lotion induces electrochemical abnormalities across the membranes of excitable cells, leading to sensory hyperexcitability, in coordination and prostration. Weeva Lotion is rapidly metabolized in mammals by ester hydrolysis to inactive metabolites which are excreted primarily in the urine. The principal metabolites of Weeva Lotion are detectable in the urine within hours of a whole body application of the cream to healthy volunteers or scabies patients. The highest levels of excretion are detectable within the first 48 hours, but very low levels of metabolites are still detectable in the urine of some individuals 28 days after treatment.
Weeva Lotion is not an eye-irritant, but the cream itself may cause marked irritation. Nursing staff who routinely apply Weeva Lotion, may wear gloves to avoid any possible irritation to the hands.
The treatment of eczematous-like reactions with corticosteroids should be withheld prior to treatment with Weeva Lotion, as there is a risk of exacerbating the scabies infestation by reducing the immune response to the mite.
There are limited data on the use of Weeva Lotion in pregnancy which provide no indication of any risk to the foetus. Furthermore, the amount of Weeva Lotion absorbed systemically following a whole body application is extremely low. The negative mutagenicity tests and the very low mammalian toxicity would suggest that any risk to the foetus following treatment with Weeva Lotion is minimal. Inspite of these, Weeva Lotion is suggested not to useduring pregnancy.
It is not known whether Weeva Lotion is excreted in human breast milk. So, it should not be used in nursing mothers.
Weeva Lotion is contraindicated in subjects with known hypersensitivity to the product, its components, other pyrethroids or pyrethrins.
There are no reports of overdosage with Weeva Lotion. It is possible that excessive application of Weeva Lotion might result in localized adverse reactions or more severe skin reactions.
Store at a cool and dry place. Protect from light. Do not freeze.
Weeva Lotion Lotion price in India 0